Chandipura Virus: A Lesser Known but Dangerous Epidemic
Keywords:
Arthropod-borne virus, Chandipura virus, Encephalitis, Genomes, Humans, India, IgM antibodies, Isolates, RNA, SandfliesAbstract
In this review, we have discussed about the chandipura virus in detail. The Chandipura Virus, a subsidiary of the Rhabdoviridae family, is the cause of this explosive outbreak in rural India. It is spread via sand flies, mosquitoes, and ticks. The virus primarily affects youngsters and is characterized by influenza-like sickness and brain dysfunctions. About 70% of cases of CHPV pediatric encephalitis that were recorded in 2003–2004 in central and south-western India resulted in death. High-grade fever, altered sensorium, vomiting, decerebrate posture, generalised convulsions, and coma are all signs of a CHPV infection. The defining feature of CHPV infection is neuroinflammation, which significantly affects the cerebral and brainstem areas. Acute encephalitis is caused by the CHPV infection. With a case fatality rate of more than 50%, the illness is marked by a high fever, headache, exhaustion, vomiting, and convulsions. Due to excessive cytokine release, immunopathology is thought to be the cause of the damage to nerve tissue. Usually, death happens 24 to 48 hours following the onset of clinical signs. According to research, CHPV replication in brain cells peaks six hours after infection, resulting in fast apoptosis. This could account for the children's early death. Based on evidence of venereal and transovarial transmission as well as virus isolations, phlebotomine sandflies are thought to be vectors for the spread of CHPV. There have been notable developments in antiviral treatments, vaccinations, preventative measures, and diagnostics. There aren't any vaccines or therapies for CHPV infection at the moment. The Cochrane Library, PubMed, and Google Scholar were used to perform an extensive literature search on CHPV cases. CHPV infections that were confirmed in laboratories. We extracted and examined data on clinical presentations, epidemiological variables, diagnostics, and outbreak features. Understanding molecular pathogenesis is crucial for developing efficacious therapies and preventive measures. The review summarises CHPV epidemiology, transmission, genome structure, replication, pathogenesis and the latest antiviral therapies and vaccine developments.
References
Buch KP, Buch PM. 576. Chandipura virus infection: Time to think beyond Enceph alitis? InOpen Forum Infectious Diseases 2025;12(1): ofae631-014). US: Oxford University Press. https://doi.org/10.1093/ofid/ofae631.014
Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, Mahadev PV, Mishra AC. An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India. Am. J. Trop. Med. Hyg. 2005; 73(3):566-70. https://doi.org/10.4269/ajtmh.2005.73.566
Adnan H, Salomon I, Ahmed M. Chandipura virus outbreak: a growing public health crisis that demands immediate action. Ann. Med. Surg. 2025; 87(1):24-6. https://doi.org/10.1097/MS9.0000000000002841
Giovanetti M, Micheli V, Mancon A, Mileto D, Rizzo A. Phylogenetic analysis of Chandipura virus: insights from a preliminary genomic study. Int. J. Mol. Sci. 2025;26(3):1021. https://doi.org/10.3390/ijms26031021
Patil VV, Shaikh AZ, Pawar SP. Chandipura virus cause of a devastating outbreak in India’s rural areas. Asian. J. Pharm. Res. 2024;14(4):392–6. https://doi.org/10.3390/pathogens13121110
Garg R, Prasad AK, Agarwala P. Chandipura virus resurgence: insights from Indian outbreaks and the path forward. Indian. J. Med. Microbiol. 2024; 52:100749. https://doi.org/10.1016/j.ijmmb.2024.100749
Brisse ME, Ly H. Chandipura virus causing large viral encephalitis outbreaks in India. Pathogens. 2024; 13:1110. https://doi.org/10.3390/pathogens13121110
Sapkal GN, Sawant PM, Mourya DT. Chandipura viral encephalitis: a brief review. Open Virol J. 2018;12(Suppl-2, M2):44. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC6142667/
Dinesh DS, Topno RK, Pandey K, Kumar R, Sahoo GC, Kumar M, et al. Chandipura virus recognized among AES for the first time in Bihar, India. Int. J. Curr. Microbiol. App. Sci. 2018; 7(12):3658–63. https://doi.org/10.20546/ijcmas.2018.712.414
Shanmugaraj B. Epidemiology and clinical characteristics of Chandipura virus. J. Zoonotic. Dis. 2025;9(1):651–7. https://doi.org/10.22034/jzd.2024.18395
Ghosh S, Basu A. Neuropathogenesis by Chandipura virus: an acute encephalitis syndrome in India. Natl. Med. J. India. 2017;30(1). Available: https://pubmed.ncbi.nlm.nih.gov/28731002/
Wilkhoo H, HS W. Chandipura Vesiculovirus: clinical manifestation, neuroinvasion and public health interventions. Int. J. Heal. Sci. Res. 2024; 14:94–102. http://dx.doi.org/10.52403/ijhsr.20240912
Gupta P, Tripathy AS. Alternative pathway of complement activation has a beneficial role against Chandipura virus infection. Med. Microbiol. Immunol. 2020;209(2):109–24. https://doi.org/10.1007/s00430-019-00648-z
Dixit BM. Sanctuary solutions: integrating the Sanskrit treasure of Ayurveda and modern sandfly control for Chandipura virus. Redshine. Arch. 2024;8(7). Available: https://chapters.redshine.in/index.php/redshine/article/view/1669
Agrawal RP, Gavande SS. Ayurvedic perspective on Chandipura virus: a critical review. Int. J. Sci. Res. 2022; ISSN:2319-7064. Available: https://www.ijsr.net/archive/v13i8/SR24815064152.pdf
Verma H, Negi MS, Mahapatra BS, Shukla A, Paul J. Evaluation of an emerging medicinal crop Kalmegh [Andrographis paniculata (Burm. f.) Wall. Ex. Nees] for commercial cultivation and pharmaceutical & industrial uses: a review. J. Pharmacogn. Phytochem. 2019;8(4):835–8. Avalable: https://www.phytojournal.com/archives/2019/vol8issue4/PartO/8-3-617-127.pdf
Niranjan A, Tewari SK, Lehri A. Biological activities of Kalmegh (Andrographis paniculata Nees). Indian. J. Nat. Prod. Resour. 2010; 1(2):125–35. Available: https://www.ozen.eco/wp-content/uploads/2020/12/Niranjan-Abhishek-Tewari-Shri-Lehri-Alok.-2010.-Biological-act.pdf
Lantz RC, Chen GJ, Solyom AM, Jolad SD, Timmermann BN. The effect of turmeric extracts on inflammatory mediator production. Phytomedicine. 2005; 12(6–7):445–52. https://doi.org/10.1016/j.phymed.2003.12.011
Subapriya R, Nagini S. Medicinal properties of neem leaves: a review. Curr. Med. Chem. Agents. 2005;5(2):149–56. https://doi.org/10.2174/1568011053174828
Prakash P, Gupta N. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian. J. Physiol. Pharmacol. 2005; 49(2):125. Available: https://pubmed.ncbi.nlm.nih.gov/16170979/
Srinivas N, Sali K, Bajoria AA. Therapeutic aspects of Tulsi unraveled: a review. J. Indian. Acad. Oral. Med. Radiol. 2016;28(1):17–23. https://doi.org/10.4103/0972-1363.189984
Sharma A, Kumar V, Thakur A, Sharma R, Rana V, Gourav A. Herbal drugs are used for the treatment of Chandipura virus. J. Adv. Futur. Res. 2024; 2(11):28–38. Available: https://rjwave.org/jaafr/papers/JAAFR2411005.pdf
Rajasekharan S, Rana J, Gulati S, Gupta V, Gupta S. Neuroinvasion by Chandipura virus. Acta. Trop. 2014; 135:122–6. https://doi.org/10.1016/j.actatropica.2014.03.028
Kumar N, Bondre VP. Re-emergence of Chandipura virus infection in India. Virulence. 2024; 15:2421218. https://doi.org/10.1080/21505594.2024.2421218
Sudeep AB, Gurav YK, Bondre VP. Changing clinical scenario in Chandipura virus infection. Indian. J. Med. Res. 2016;143(6):712–21. https://doi.org/10.4103/0971-5916.191929
Patel M, Goel AD, Bhardwaj P, Joshi N, Kumar N, Gupta MK, et al. Emerging. and re-emerging viral infections in India. J. Prev. Med. Hyg. 2021;62(3):e628. https://doi.org/10.15167/2421-4248/jpmh2021.62.3.1899
Karanam SK, Uppala PK, Kandra NV, Edhi S. Chandipura virus: an emerging neurotropic pathogen and its public health implications in India. Discov Public Heal. 2024;21(1):245. Available: https://d-nb.info/1358291071/34
Menghani S, Chikhale R, Raval A, Wadibhasme P, Khedekar P. Chandipura virus: an emerging tropical pathogen. Acta. Trop. 2012;124(1):1–14. https://doi.org/10.1016/j.actatropica.2012.06.001